April M. Jorge

Rheumatology

55 Fruit St
Boston, MA 02114

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Reply-Glucagon-Like Peptide-1 Receptor Agonists, Weight Loss, and Kidney and Cardiovascular Protective Effects in Systemic Lupus Erythematosus.

Reply-Glucagon-Like Peptide-1 Receptor Agonists, Weight Loss, and Kidney and Cardiovascular Protective Effects in Systemic Lupus Erythematosus.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: July 30, 2026

Cardiometabolic protective mechanisms and efficacy of sodium-glucose cotransporter 2 inhibitors (SGLT2i) in SLE.

Cardiometabolic protective mechanisms and efficacy of sodium-glucose cotransporter 2 inhibitors (SGLT2i) in SLE.

Journal: Rheumatology (Oxford, England)

Published: February 02, 2026

Development and initial validation of a brief measure of uncertainty in rheumatic disease.

Development and initial validation of a brief measure of uncertainty in rheumatic disease.

Journal: Journal of health psychology

Published: January 31, 2026

Systemic Lupus Erythematosus: What Every Clinician Needs to Know.

Systemic Lupus Erythematosus: What Every Clinician Needs to Know.

Journal: Mayo Clinic proceedings

Published: January 14, 2026

Optimizing Hydroxychloroquine in Lupus Treatment: Looking Beyond the 5-mg/kg Weight-Based Dosing Cutoff.

Optimizing Hydroxychloroquine in Lupus Treatment: Looking Beyond the 5-mg/kg Weight-Based Dosing Cutoff.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: November 14, 2025

Integrating Patient-Reported Quality Measures in Systemic Lupus Erythematosus: Development of the American College of Rheumatology Implementation Guide.

Integrating Patient-Reported Quality Measures in Systemic Lupus Erythematosus: Development of the American College of Rheumatology Implementation Guide.

Journal: Arthritis care & research

Published: November 04, 2025

2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus.

2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus.

Journal: Arthritis care & research

Published: May 27, 2025

2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus.

2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: May 27, 2025

Renal Replacement Therapy in Lupus Nephritis-Related End-Stage Kidney Disease: A Systematic Review and Meta-Analysis.

Renal Replacement Therapy in Lupus Nephritis-Related End-Stage Kidney Disease: A Systematic Review and Meta-Analysis.

Journal: ACR open rheumatology

Published: May 22, 2025

Glucagon-Like Peptide-1 Receptor Agonist Use and the Risk of Adverse Cardiac and Kidney Outcomes Among Patients With Systemic Lupus Erythematosus and Lupus Nephritis.

Glucagon-Like Peptide-1 Receptor Agonist Use and the Risk of Adverse Cardiac and Kidney Outcomes Among Patients With Systemic Lupus Erythematosus and Lupus Nephritis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: March 30, 2025

2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis.

2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: February 27, 2025

2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis.

2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis.

Journal: Arthritis care & research

Published: February 27, 2025

Showing 1-12 of 53

Last Updated: 09/26/2026